- Home
- SEDG vs RCUS Comparison
SEDG vs RCUS Comparison
Compare SEDG & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEDG
- RCUS
- Stock Information
- Founded
- SEDG 2006
- RCUS 2015
- Country
- SEDG Israel
- RCUS United States
- Employees
- SEDG N/A
- RCUS N/A
- Industry
- SEDG Semiconductors
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- SEDG Technology
- RCUS Health Care
- Exchange
- SEDG Nasdaq
- RCUS Nasdaq
- Market Cap
- SEDG 976.4M
- RCUS 1.2B
- IPO Year
- SEDG 2015
- RCUS 2018
- Fundamental
- Price
- SEDG $16.18
- RCUS $7.86
- Analyst Decision
- SEDG Hold
- RCUS Strong Buy
- Analyst Count
- SEDG 26
- RCUS 10
- Target Price
- SEDG $26.62
- RCUS $29.50
- AVG Volume (30 Days)
- SEDG 2.4M
- RCUS 872.5K
- Earning Date
- SEDG 05-07-2025
- RCUS 05-07-2025
- Dividend Yield
- SEDG N/A
- RCUS N/A
- EPS Growth
- SEDG N/A
- RCUS N/A
- EPS
- SEDG N/A
- RCUS N/A
- Revenue
- SEDG $901,456,000.00
- RCUS $258,000,000.00
- Revenue This Year
- SEDG $23.36
- RCUS N/A
- Revenue Next Year
- SEDG $35.43
- RCUS $28.07
- P/E Ratio
- SEDG N/A
- RCUS N/A
- Revenue Growth
- SEDG N/A
- RCUS 120.51
- 52 Week Low
- SEDG $10.24
- RCUS $7.56
- 52 Week High
- SEDG $73.60
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- SEDG 49.11
- RCUS 27.90
- Support Level
- SEDG $15.55
- RCUS $8.02
- Resistance Level
- SEDG $17.97
- RCUS $8.57
- Average True Range (ATR)
- SEDG 1.16
- RCUS 0.44
- MACD
- SEDG -0.13
- RCUS -0.01
- Stochastic Oscillator
- SEDG 47.63
- RCUS 12.19
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.